NG

Nishant Garg

Active Director Director DIN 09474950
DIN 09474950 First appointment Jan 2022 Primary industry Pharma
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Jan 2022
Shareholding value •••• Premium profile

About Nishant Garg

Data last updated:

Nishant Garg is a Director at Semlon Remedies Private Limited (since 2022). The company operates in Pharma. Semlon Remedies Private Limited reported revenue of ₹32,420 (FY 2024).

DIN 09474950
Primary Designation Director
Industry Pharma
First Appointment 20 Jan 2022
Oldest Company Age 4 yrs
Largest company Semlon Remedies Private Limited · ₹32,420 (FY 2024)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Semlon Remedies Private Limited U24290HR2022PTC100698
Director20 Jan 20222022₹32,420 (FY 2024)Active

Board colleagues of Nishant Garg

Directorship timeline

Open interactive timeline →
Semlon Remedies Private Limited
Premium access

Shareholding and investment profile for Nishant Garg

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Nishant Garg

Nishant Garg currently holds 1 directorship: Semlon Remedies Private Limited (Director, since 20 Jan 2022, revenue ₹32,420 (FY 2024)).

Nishant Garg was first appointed on 20 Jan 2022 as Director at Semlon Remedies Private Limited.

The current boards of Nishant Garg's companies include Ishender Mohan (Semlon Remedies Private Limited), Kashish Singal (Semlon Remedies Private Limited), Manu Sharma (Semlon Remedies Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available